About us


2011 (total impact fac. 113.223 ave. 5.392)

Phung, T. T. B., Sugamata, R., Uno, K., Aratani, Y., Ozato, K., Kawachi, S., Nguyen, L. T., Nakayama, T., and Suzuki, K.: Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells. Microbiol. Immunol. 55:874-884 (2011). (1.227)

Kidoya, H., Kunii, N., Naito, H., Muramatsu, T., Okamoto, Y., Nakayama, T., and Takakura, N.: The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy. Oncogene 31:3254-3264 (2011). (7.414)

Endo, Y., Iwamura, C., Kuwahara, M., Suzuki, A., Sugaya, K., Tumes, D. J., Tokoyoda, K., Hosokawa, H., Yamashita, M., and Nakayama, T.: Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35:733-745 (2011). (24.221)

Tsuyusaki, J., Kuroda, F., Kasuya, Y., Ishizaki, S., Yamauchi, K., Sugimoto, H., Kono, T., Iwamura, C., Nakayama, T., and Tatsumi, K.: Cigarette smoke-induced pulmonary inflammation is attenuated in CD69-deficient mice. J. Recept. Sig. Transduct. Res. 31:434-439 (2011). (1.822)

Takahashi, K., Hirose, K., Kawashima, S., Niwa, Y., Wakashin, H., Iwata, A., Tokoyoda, K., Renauld, J.-C., Iwamoto, I., Nakayama, T., and Nakajima, H.: IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J. Allergy Clin. Immunol. 128:1067-1076 (2011). (9.273)

Yamauchi, K., Kasuya, Y., Kuroda, F., Tanaka, K., Tsuyusaki, J., Ishizaki, S., Matsunaga, H., Iwamura, C., Nakayama, T., and Tatsumi, K.: Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir. Res. 12:131 (2011). (2.859)

Exley, M. A., and Nakayama, T.: NKT-cell-based immunotherapies in clinical trials. Clin. Immunol. 140:117-118 (2011). (3.932)

Motohashi, S., Okamoto, Y., Yoshino, I., and Nakayama, T.: Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin. Immunol. 140:167-176 (2011). (3.932)

Nagao, T., Suzuki, K., Utsunomiya, K., Matsumura, M., Saiga, K., Wang, P.-C., Minamitani, H., Aratani, Y., Nakayama, T., and Suzuki, K.: Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody. Nephrol. Dial. Transplant. 26:2752-2760 (2011). (3.564)

Kitajima, M., Ito, T., Tumes, D. J., Endo, Y., Onodera, A., Hashimoto, K., Motohashi, S., Yamashita, M., Nishimura, T., Ziegler, F. S., and Nakayama, T.: Memory type 2 helper T cells induce long-lasting anti-tumor immunity by activating natural killer cells. Cancer Res. 71:4790-4798 (2011). (8.234)

Fujii, H., Ato, M., Takahashi, Y., Otake, K., Hashimoto, S., Kaji, T., Tsunetsugu-Yokota, Y., Fujita, M., Adachi, A., Nakayama, T., Taniguchi, M., Koyasu, S., and Takemori, T.: HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice. Int. Immunol. 23:433-441 (2011). (3.301)

Asada, S., Kuroda, M., Aoyagi, Y., Fukaya, Y., Tanaka, S., Konno, S., Tanio, M., Aso, M., Satoh, K., Okamoto, Y., Nakayama, T., Saito, Y., and Bujo, H.: Ceiling culture-derived proliferative adipocytes retain high adipogenic potential suitable for use as a vehicle for gene transduction therapy. Am. J. Physiol. Cell Physiol. 301: C181-185 (2011). (3.817)

Kitajima, M., Lee, H.-C., Nakayama, T., and Ziegler, S. F.: TSLP enhances the function of helper type2 cells. Eur. J. Immunol. 41:1862-1871 (2011). (4.942)

Horiuchi, S., Onodera, A., Hosokawa, H., Watanabe, Y., Tanaka, T., Sugano, S., Suzuki, Y., and Nakayama, T.: Genome-wide analysis reveals unique regulation of transcription of Th2-specific genes by GATA3. J. Immunol. 186:6378-6389 (2011). (5.745)

Hirasaki, Y., Iwamura, C., Yamashita, M., Ito, T., Kitajima, M., Shinoda, K., Namiki, T., Terasawa, K., and Nakayama, T.: Repressor of GATA negatively regulates murine contact hypersensitivity through the inhibition of type-2 allergic responses. Clin. Immunol. 139:267-276 (2011). (3.932)

Fujimura, T., Yonekura, S., Horiguchi, S., Taniguchi, Y., Saito, A., Yasueda, H., Inamine, A., Nakayama, T., Takemori, T., Taniguchi, M., Sakaguchi, M., and Okamoto, Y.: Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in two-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin. Immunol. 139:65-74 (2011). (3.932)

Yamashita, J., Iwamura, C., Sasaki, T., Mitsumori, K., Ohshima, K., Hada, K., Hara, N., Takahashi, M., Kaneshiro, Y., Tanaka, H., Kaneko, K., and Nakayama, T.: ApolipoproteinA-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J. Immunol. 186:3410-3420 (2011). (5.745)

Yamasaki, K., Horiguchi, S., Kurosaki, M., Kunii, N., Nagato, K., Hanaoka, H., Shimizu, N., Ueno, N., Yamamoto, S., Taniguchi, M., Motohashi, S., Nakayama, T., and Okamoto, Y.: Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clin. Immunol. 138:255-265 (2011). (3.932)

Aoyagi, T., Yamamoto, N., Hatta, M., Tanno, D., Miyazato, A., Ishii, K., Suzuki, K., Nakayama, T., Taniguchi, M., Kunishima, H., Hirakata, Y., Kaku, M., and Kawakami, K.: Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes. Int. Immunol. 23:97-108 (2011). (3.301)

Phung, T. T. B., Luong, S. T., Kawachi, S., Nunoi, H., Nguyen, L. T., Nakayama, T., and Suzuki, K.: Interleukin 12 and myeloperoxidase (MPO) in Vietnamese children with acute respiratory distress syndrome due to Avian influenza (H5N1) infection. J. Infect. 62:104-106 (2011). (3.805)

Kurosaki, M., Horiguchi, S., Yamasaki, K., Uchida, Y., Motohashi, S., Nakayama, T., Sugimoto, A., and Okamoto, Y.: Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer. Cancer Immunol. Immunother. 60:207-215 (2011). (4.293)